Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pancreatic involvement in Erdheim-Chester disease: a case report and review of the literature. | BMC Gastroenterol | 2022 | 35729495 | PubTator, text mining | PubMed |
| Developing Biliary Atresia-like Model by Treating Human Liver Organoids with Polyinosinic:Polycytidylic Acid (Poly (I:C)). | Curr Issues Mol Biol | 2022 | 35723330 | PubTator, text mining | PubMed |
| Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer. | Front Pharmacol | 2022 | 35721193 | PubTator, text mining | PubMed |
| Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents. | Front Mol Biosci | 2022 | 35720115 | PubTator, text mining | PubMed |
| Extranodal Rosai-Dorfman Disease- a Review of Diagnostic Testing and Management. | J Community Hosp Intern Med Perspect | 2022 | 35712692 | PubTator, text mining | PubMed |
| A novel antiproliferative PKCα-Ras-ERK signaling axis in intestinal epithelial cells. | J Biol Chem | 2022 | 35697074 | PubTator, text mining | PubMed |
| First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy. | Front Med (Lausanne) | 2022 | 35692538 | PubTator, text mining | PubMed |
| The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma. | Transl Oncol | 2022 | 35691247 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | Nucleic Acids Res | 2022 | 35687106 | PubTator, text mining | PubMed |
| Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors. | Int J Mol Sci | 2022 | 35682627 | PubTator, text mining | PubMed |
| Tracking mutation and drug-driven alterations of oncokinase conformations. | Memo | 2022 | 35677701 | PubTator, text mining | PubMed |
| RAF1 promotes lymphatic metastasis of hypopharyngeal carcinoma via regulating LAGE1: an experimental research. | J Transl Med | 2022 | 35668458 | PubTator, text mining | PubMed |
| A 3D-printed scaffold-based osteosarcoma model allows to investigate tumor phenotypes and pathogenesis in an in vitro bone-mimicking niche. | Mater Today Bio | 2022 | 35665234 | PubTator, text mining | PubMed |
| Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy. | Acta Pharm Sin B | 2022 | 35646548 | PubTator, text mining | PubMed |
| Identification of Inhibitors and Drug Targets for Human Adenovirus Infections. | Viruses | 2022 | 35632701 | PubTator, text mining | PubMed |
Sequencing of Cutaneous Squamous Cell Carcinoma Primary Tumors and Patient-Matched Metastases Reveals ALK as a Potential Driver in Metastases and Low Mutational Concordance in Immunocompromised Patients. | JID Innov | 2022 | 35620707 | PubTator, text mining | PubMed |
| ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1. | Mol Cell | 2022 | 35613620 | PubTator, text mining | PubMed |
| LINC01232 Promotes Metastasis and EMT by Regulating miR-506-5p/PAK1 Axis in Gastric Cancer. | Cancer Manag Res | 2022 | 35592108 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. | J Oncol | 2022 | 35586209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=24